Q1 2018 Holdings
Filed 2018-05-15 | 137 holdings | $445.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals(ALNY) | COM | 02043Q107 | $152.5M | 1,280,802 | 34.3% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $64.3M | 982,647 | 14.4% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $62.8M | 2,208,812 | 14.1% |
| Argenx SE(ARGX) | COM | 04016X101 | $43.2M | 537,361 | 9.7% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $23.5M | 2,462,400 | 5.3% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $23.1M | 3,085,458 | 5.2% |
| Agio Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $20.4M | 250,000 | 4.6% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $17.6M | 3,821,102 | 4.0% |
| Cellectis S A(CLLS) | SPONSORED ADS | 15117K103 | $9.5M | 300,000 | 2.1% |
| Caredx Inc(CDNA) | COM | 14167L103 | $8.3M | 1,040,676 | 1.9% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $6.2M | 275,000 | 1.4% |
| Biogen Inc(BIIB) | COM | 09062X103 | $5.5M | 20,000 | 1.2% |
| Arrowhead Pharmaceuticals Inc(ARWR) | COM | 04280A100 | $2.6M | 365,445 | 0.6% |
| Champions Oncology Inc(CSBR) | COM NEW | 15870P307 | $1.3M | 366,973 | 0.3% |
| Beigene LTD(ONC) | SPONSORED | 07725L102 | $958.0K | 5,700 | 0.2% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $394.9K | 4,761,989 | 0.1% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $301.2K | 20,024,424 | 0.1% |
| Global Blood Therapeutics in | COM | 37890U108 | $241.0K | 4,989,066 | 0.1% |
| Zogenix Inc | COM NEW | 98978L204 | $159.0K | 3,970,357 | 0.0% |
| LA Jolla Pharmaceutical Co(LJPC) | COM PAR $.0001 2 | 503459604 | $128.5K | 4,313,611 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $104.1K | 6,162,202 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $97.4K | 873,450 | 0.0% |
| Abiomed Inc(ABMDEUR) | COM | 003654100 | $96.7K | 332,449 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $94.5K | 1,030,434 | 0.0% |
| Dova Pharmaceuticals Inc(DOVA) | COM | 25985T102 | $75.4K | 2,780,977 | 0.0% |
| Corium International Inc | COM | 21887L107 | $72.9K | 6,357,133 | 0.0% |
| Retrophin Inc | COM | 761299106 | $71.8K | 3,212,871 | 0.0% |
| Biohaven Pharmaceutical Hldg Co L(BHVN) | COM | G11196105 | $71.2K | 2,927,449 | 0.0% |
| Menlo Therapeutics Inc | COM | 586858102 | $60.1K | 1,598,958 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $59.3K | 1,516,259 | 0.0% |
| Albireo Pharma Inc(BDQM) | COM | 01345P106 | $55.5K | 1,704,330 | 0.0% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $48.3K | 2,093,498 | 0.0% |
| Merit MED SYS Inc(MMSI) | COM | 589889104 | $47.4K | 1,045,013 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $40.7K | 834,679 | 0.0% |
| Xencor Inc(XNCR) | COM | 98401F105 | $39.5K | 1,318,095 | 0.0% |
| Avexis Inc | COM | 05366U100 | $34.2K | 276,400 | 0.0% |
| VBI Vaccines Inc(VAC2USD) | COM NEW | 91822J103 | $33.8K | 9,665,843 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $33.7K | 2,802,821 | 0.0% |
| Uniqure NV(QURE) | COM | N90064101 | $32.8K | 1,394,628 | 0.0% |
| Puma Biotechnology Inc(PBYI) | COM | 74587V107 | $30.1K | 442,179 | 0.0% |
| Solid Biosciences Inc | COM | 3422E1055 | $29.5K | 3,927,222 | 0.0% |
| Quotient LTD | COM | G73268107 | $28.4K | 6,033,020 | 0.0% |
| Irhythm Technologies Inc(IRTC) | COM | 450056106 | $26.4K | 419,706 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $26.3K | 881,106 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $24.8K | 151,898 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $24.7K | 237,281 | 0.0% |
| Neptune Technologies Bioreso | COM | 64077P108 | $24.1K | 8,574,015 | 0.0% |
| Assembly Biosciences Inc | COM | 045396108 | $23.4K | 476,626 | 0.0% |
| Audentes Therapeutics Inc(BOLDEUR) | COM | 05070R104 | $22.7K | 756,215 | 0.0% |
| Kadmon Hldgs Inc(KDMN) | COM | 48283N106 | $22.0K | 5,165,746 | 0.0% |